The plasma binding protein for vitamin D is a site of discrimination against vitamin D-2 compounds by the chick

Biochim Biophys Acta. 1988 Apr 14;965(1):16-21. doi: 10.1016/0304-4165(88)90145-6.

Abstract

The binding of 25-hydroxy-[26,27-3H]vitamin D-3 and 25-hydroxy-[26,27-3H]vitamin D-2 to the vitamin D binding protein in the plasma of both rats and chicks has been studied. In the case of rats, sucrose density gradient analysis, competitive displacement, and Scatchard analysis demonstrate that 25-hydroxyvitamin D-3 and 25-hydroxyvitamin D-2 are bound equally well to the vitamin D binding protein. In contrast, 25-hydroxyvitamin D-2 is poorly bound, while 25-hydroxyvitamin D-3 is tightly bound to the vitamin D binding protein in chick plasma. On the other hand, the chick intestinal receptor binds 1,25-dihydroxyvitamin D-2 and 1,25-dihydroxyvitamin D-3 equally well with a KD of 7.10(-11) M for both compounds. These results strongly suggest that the failure of the plasma transport protein in chicks to bind the vitamin D-2 compounds may be responsible for their relative ineffectiveness in these animals.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 25-Hydroxyvitamin D 2
  • Animals
  • Calcifediol / blood
  • Centrifugation, Density Gradient
  • Chickens
  • Ergocalciferols / analogs & derivatives*
  • Ergocalciferols / blood
  • Male
  • Rats
  • Species Specificity
  • Vitamin D-Binding Protein / blood*

Substances

  • Ergocalciferols
  • Vitamin D-Binding Protein
  • 25-Hydroxyvitamin D 2
  • Calcifediol